MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 541 SEK -4.25% Market Closed
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Operating Income Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Operating Income
kr294.3m
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
32%
AddLife AB
STO:ALIF B
Operating Income
kr805m
CAGR 3-Years
5%
CAGR 5-Years
36%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Operating Income
-kr100m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Operating Income
kr351m
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
22%
G
Genovis AB
STO:GENO
Operating Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
31%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Operating Income
kr21.7m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Operating Income?
Operating Income
294.3m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Operating Income amounts to 294.3m SEK.

What is MedCap AB (publ)'s Operating Income growth rate?
Operating Income CAGR 10Y
32%

Over the last year, the Operating Income growth was 47%. The average annual Operating Income growth rates for MedCap AB (publ) have been 38% over the past three years , 33% over the past five years , and 32% over the past ten years .

Back to Top